Delivery Order SPE2DB22D3501-SPE2DB25FTY93

Award Date 12/30/24
Potential Completion Date 1/22/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $8,067.35, and has an ultimate completion date of January 17, 2025. The contract covers the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug IBRANCE 125 MG CAPSULE 21S. The contract has a ceiling value of $8,061.38 and runs through January 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,067.35 firm fixed-price contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,796.30 contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a specialty cancer medication. The award has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 21, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 100 MG CAPSULE 21S. The $23,388.90 fixed-price contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, which serve as primary vehicles for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,792.08 firm fixed-price contract is for the delivery of Ibrance 125 mg tablet packages, with a completion date of December 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distributor. The order, valued at $7,792.08, is for the supply of 125 mg Ibrance capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC...
This is a federal delivery order contract valued at $8,065.75, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG CAPSULE 21S, a prescription medication, with a completion date of January 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
The Defense Logistics Agency (DLA) awarded a $7,796.30 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, which has no set-aside designation, is for the delivery of 4564522899 IBRANCE 100 MG TABLET 7S, a pharmaceutical product. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTY93
    Delivery Order

This is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, and has a ceiling value of $8,067.35. The contract is a firm-fixed price delivery order with a period of performance through January 22, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 3/31/25, 9:33 AM